These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2431033)

  • 1. T lymphocyte recognition of insolubilized peptide antigen.
    Thomas DW; Solvay MJ
    J Immunol; 1986 Dec; 137(11):3401-5. PubMed ID: 2431033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
    Peterson LB; Wilner GD; Thomas DW
    J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ia-independent binding of peptide antigen to the T cell receptor.
    Esch TR; Thomas DW
    J Immunol; 1990 Dec; 145(12):3972-8. PubMed ID: 2147931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.
    Thomas DW; Schauster JL; Hoffman MD; Wilner GD
    J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating and helper T lymphocytes display distinct fine specificities in response to human fibrinopeptide B.
    Peterson LB; Wilner GD; Thomas DW
    J Immunol; 1983 Jun; 130(6):2542-5. PubMed ID: 6189893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Ia in the formation of a T cell antigen-recognition complex.
    Esch TR; McKean DJ; Thomas DW
    J Immunol; 1990 Dec; 145(12):3979-84. PubMed ID: 2258604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides related to the antigenic determinant block T cell recognition of the native protein as processed by antigen-presenting cells.
    Lakey EK; Margoliash E; Flouret G; Pierce SK
    Eur J Immunol; 1986 Jul; 16(7):721-7. PubMed ID: 2424770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two roles for Ia in antigen-specific T cell activation. II. Toward a Velcro model of antigen recognition.
    Kim KH; Thomas DW
    J Immunol; 1988 Apr; 140(8):2500-7. PubMed ID: 3258611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.
    Kovac Z; Schwartz RH
    J Immunol; 1985 May; 134(5):3233-40. PubMed ID: 2580020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
    Tite JP; Sloan A; Janeway CA
    J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
    Walden P; Nagy ZA; Klein J
    J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sites of antigen-T cell and antigen-MHC interactions overlap.
    Hansburg D; Appella E
    J Immunol; 1985 Dec; 135(6):3712-8. PubMed ID: 2415583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
    Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
    J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by cells that are not of bone marrow origin.
    Geppert TD; Lipsky PE
    Reg Immunol; 1989; 2(1):60-71. PubMed ID: 2518360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.
    Moreno J; Lipsky PE
    J Immunol; 1986 May; 136(10):3579-87. PubMed ID: 3084635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
    Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
    J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.